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The Use of Liver Microsome In-Vitro Methods to Study Toxicant
Metabolism and Predict Species Efficacy
Katherine E. Horak, Chad R. Wermager, and Thomas M. Primus
USDA APHIS WS National Wildlife Research Center, Fort Collins, Colorado
Liver microsomes are used extensively in human pharmaceutical development to study the metabolism of
compounds of interest; however, they are rarely part of the development of toxicants for the control of wildlife. Liver microsome
samples from wildlife of interest would likely be harvested in the field without access to laboratory perfusion equipment. Therefore,
the metabolic activity of microsomes from perfused and non-perfused livers was compared. There was no significant difference in
diphacinone metabolism by liver microsomes from both perfused and non-perfused Wistar rat livers, although chlorophacinone
metabolism was significantly different. There are often significant differences in metabolism between species that can be utilized to
increase toxicant specificity. In this study bobwhite quail liver microsomes metabolized more diphacinone and chlorophacinone
than both Wistar and brown rats. This information can be used during toxicant development to help determine the most sensitive
species to toxicants of interest. Additionally, the effect of incubation time on toxicant metabolism was examined to determine
optimal experimental conditions. The data from these experiments support the use of liver microsomes as a tool to be used during
toxicant development to provide information that can be incorporated into whole animal studies.
chlorophacinone, cytochrome p450, diphacinone, liver microsomes, metabolism, rodenticides,
toxicant development
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INTRODUCTION
Many of the toxicants used to control wildlife, such as
chlorophacinone, diphacinone, and zinc phosphide, are
formulated for oral delivery. Although this method is
convenient and offers numerous benefits, drugs that are
absorbed through the GI tract will, most often, pass
through the portal circulation into the liver prior to
reaching the site of action. The liver is the major organ
responsible for biotransformation and metabolism. This
metabolism serves to detoxify and ultimately eliminate
chemicals from the body. Efficient metabolism and
elimination of toxicants serves as an evolutionary advantage, but poses a major hurdle in wildlife toxicant
development.
Toxicant metabolism is characterized by two types of
enzymatic reactions, namely phase I and phase II. Phase
I reactions involve oxidation, reduction, or hydrolysis and
are performed by a class of enzymes called cytochrome
p450 (Klassen 2001). These enzymes are located in the
endoplasmic reticulum of many tissues but occur in very
high density in the liver. Metabolic reactions catalyzed
by cytochrome p450 enzymes can reduce the toxicity of a
compound by increasing its water solubility, thereby
enhancing excretion. Phase I reactions may also produce
metabolites with greater toxicity than the parent
compound. These processes can be examined through
the isolation of and experimentation using liver
microsomes.
Early knowledge regarding metabolic fate of potential
toxicants for the control of wildlife population helps in
the development process by allowing for the selection of
the most promising candidates, based on criteria such as
their efficacy, duration of action, or threat to non-target
species. By isolating liver microsomes, multiple in-vitro
experiments can be performed to determine the extent of
metabolism and possible interactions with other

chemicals that have affinity for the same enzymes
(Pelkonen et al. 1998, Wrighton et al. 1993).
In addition to helping in the toxicant development
process, liver microsomes can be used to assist in the
determination of possible risks to non-target species.
Often the metabolic profiles of species will differ, which,
while it poses a problem in veterinary medicine, can be
exploited during toxicant development (Lewis et al. 1998,
Fink-Gremmels 2008). If metabolic differences between
target and a non-target species are identified, it remains
possible to modify toxicants to increase toxicity to the
species of interest, while decreasing risks to non-target
species.
Although much research has been done in the human
health sciences using liver microsomes and metabolic
determination, this line of research is just beginning to be
used in wildlife management. Unlike conventional
laboratory settings, harvesting livers for microsome
isolation from wildlife species often occurs in the field
with limited availability to instrumentation, limiting the
tissue preparation that could be done. To test the viability
of microsomes isolated using field techniques, a series of
experiments were conducted to compare saline perfused
and non-perfused microsomes. Also, differences in
metabolism between Wistar rats, brown rats, and
bobwhite quail were investigated. Finally, the effects of
microsomal incubation time on total metabolism were
characterized.
METHODS
Study Animals
Livers were harvested from Wistar and brown rats
(Rattus norvegicus) and bobwhite quail (Colinus virginianus). Following euthanasia by CO2, a longitudinal
incision was made in the abdomen, and the liver was
removed and weighed. The tissue was rinsed thoroughly
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and either perfused with ice-cold 0.9% NaCl or
immediately frozen in liquid nitrogen. The perfusion was
continued until the liver appeared blanched; the perfused
tissue was then snap-frozen in liquid nitrogen. The frozen
samples were stored at -80 C until further processing.
Test Solutions
All test fortification formulations consisted of diphacinone or chlorophacinone solutions at approximately 40
ppm in phosphate (0.010 M) solutions buffered at a pH of
7.4. Solutions of magnesium chloride, phosphate buffer,
and NADH were all 0.010 M. Homogenization buffer
was as follows: sucrose 250 mM, HEPES 50 mM, KCl
25 mM, MgCl2 5 mM, EDTA 0.1 mM, adjust pH to 7.4.
Cofactor solution was made by adding 11.5 mg NADP
sodium salt, 5.2 mg glucose-6-phosphate, and 50 L
glucose-6-phosphate dehydrogenase to 950 L 0.01 M
MgCl in phosphate buffer.
Liver Microsome Preparation
Livers microsomes were isolated using differential
centrifugation according to the method by Pelkonen et al.
(1974) with minor alterations. Frozen liver samples were
minced, weighed, and transferred to a Teflon pestle/glass
homogenizer with 2 volumes (w/v) homogenization
buffer with the addition of phenylmethanesulfonyl
fluoride (Sigma) 2.5 L/ mL homogenization buffer. The
tissue was homogenized with 6 passes of the Teflon
pestle homogenizer (Wheaton Overhead Stirrer, Wheaton
Science Products, Millville, NJ). The homogenates were
centrifuged at 10,000 g for 10 min at 4 C (Beckman
Coulter Avanti J-301, Beckman Coulter Inc., Brea, CA).
The supernatants were transferred to a clean centrifuge
tube and spun at 15,000 g for 20 minutes at 4 C. The
supernatant was then transferred to ultracentrifuge tubes
and spun at 105,000 g for 60 minutes at 4 C. The pellets
were then washed with approximately 1 mL homogenization buffer, transferred to the Teflon pestle/glass
homogenizer and resuspended in homogenization buffer
(1 g w/ 0.8 mL vol), and spun at 105,000 g for 60 minutes
at 4 C. The supernatants were discarded, and the remaining pellets were resuspended in homogenization buffer
using Teflon pestle/glass homogenizer (1:1, w:v) and
frozen at -80 C.
Microsome Incubation
Microsome incubations were performed using 50 L
microsome extract, 50 L cofactor solution, the analyte,
and 0.01 M phosphate buffer added to bring volume to
500 L. These incubations contained 2.4 ppm of either
diphacinone or chlorophacinone. Incubations were done
at 37 C for 60 minutes unless otherwise noted.
Residue Determination
Chlorophacinone and diphacinone residue determination was completed by quenching 0.400 mL of the
incubation solution with 0.600 mL of methanol
containing 5 mM tetrabutylammonium phosphate and
vortex mixing. These samples are filtered with 0.45 µm
Teflon syringe filters prior to analysis by reverse phase
ion-pairing high performance liquid chromatography
(HPLC) using the following parameters: 55:45 methanol:

water w/5 mM tetrabutylammonium phosphate, 10 mM
phosphate buffer @ pH = 8.5, octadecyl silane column
150 mm × 3.0 mm particle size 3 µm at 0.300 mL/min at
35 C, UV detection at 325 nm with UV spectral
confirmation using an Agilient 1100 with ChemStation
software (Agilent Technologies Inc., Santa Clara, CA).
Statistical Methods
Data are representative of 4 samples per group and are
expressed as mean ± SEM. Data were tested for homogeneity of variance and normality. The differences
between groups were analyzed using Student’s t-test.
RESULTS
Metabolic activity of microsomes from both perfused
and non-perfused Wistar rat livers was examined using
both diphacinone and chlorophacinone as substrates
(Figure 1). Perfusion did not significantly affect the
percent of diphacinone metabolized, although there was a
significant difference in the amount of chlorophacinone
metabolized between microsomes from the perfused
livers (60% chlorophacinone metabolized) and nonperfused livers (52% metabolized) (p = 0.05). Comparing perfused liver metabolism of chlorophacinone and
diphacinone showed that more diphacinone is metabolized than chlorophacinone. Microsomes extracted from
perfused livers metabolized 95% of diphacinone and only
60% of chlorophacinone in the 60-minute incubation (p <
0.01). The same pattern occurred in microsomes from
non-perfused livers, with 91% of diphacinone being
metabolized and 52% of chlorophacinone (p < 0.01).

*

†‡

* p = 0.002 compared to perfused diphacinone metabolism.
† p = 0.006 compared to non-perfused diphacinone metabolism.
‡:p = 0.05 compared to perfused chlorophacinone metabolism.

Figure 1. Percent diphacinone metabolized (average ±
SEM) in incubations using liver microsomes from
perfused and non-perfused Wistar rat livers.

To investigate species differences in metabolism, liver
microsomes from Wistar rats, brown rats, and bobwhite
quail were incubated with diphacinone and chlorophacinone (Figure 2). Wistar rats metabolized significantly
less chlorophacinone than both brown rats and bobwhite
quail (53%, 66%, and 71% respectively, p < 0.05). The
same trend was true for diphacinone, although the
difference in metabolism is only significant between
Wistar rats and bobwhite quail, with Wistar rats metabolizing 78% of the diphacinone, brown rats metabolizing
86%, and bobwhite quail metabolizing 93% (p < 0.05).
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In each species tested, the metabolism of diphacinone
was significantly higher than that of chlorophacinone.
Wistar rats had a difference in metabolism between
diphacinone and chlorophacinone of 25%, in brown rats
the difference was 20%, and in bobwhite quail the
difference was 22% (p < 0.05).

p < 0.05 compared to Wistar rat metabolism

Figure 2. Percent diphacinone and chlorophacinone
metabolized by liver microsomes from Wistar rats, brown
rats, and bobwhite quail.

Figure 3. Time course study comparing percent of
diphacinone metabolized by Wistar rat and bobwhite quail
microsomes following 30, 60, 90, and 120 minutes of
incubation.

The effect of incubation time on amount of
diphacinone metabolized was investigated using both
Wistar rats and bobwhite quail. As incubation time
increased so did the percent of diphacinone metabolized,
from 60% after 30 minutes of incubation to 83%
following 120 minutes of incubation. The bobwhite quail
data showed the same increase in percent metabolized
with increasing incubation time. After 30 minutes of
incubation, bobwhite quail metabolized 61% of the
diphacinone, increasing to 90% with 120 minutes of
incubation (Figure 3).
DISCUSSION
For liver microsomes to be a beneficial tool used in
the development of compounds for the control of wildlife,
livers must often be harvested in the field where access to
laboratory equipment is limited. Specifically, it would be

beneficial if livers could be harvested in the field without
the burden of tissue perfusion with saline. Therefore, the
metabolic activity of microsomes from non-perfused
livers was compared with those harvested using the
traditional perfusion methodology. There was not a
significant difference in diphacinone metabolism between
the two groups, although there was a significant difference in chlorophacinone metabolism. The important information from microsome experiments used in toxicant
development is the relative amount of metabolism of
various compounds. There was no significant difference
in the ratios of chlorophacinone to diphacinone metabolized between perfused and non-perfused liver microsomes (data not shown). Since comparisons of the
metabolism of chemicals used for control would, in
theory, be performed with non-perfused livers, the
difference in metabolism between perfused and nonperfused would not affect results. Use of microsomes
from non-perfused livers will still enable researchers to
screen possible toxicants to streamline the development
process. By eliminating the perfusion step, harvesting
livers for subsequent microsome extraction becomes a
technique that can realistically be done by technicians in
the field with little additional training.
It is possible to study the metabolic profiles of a wide
variety of animals through the use of liver microsomes.
These in-vitro experiments enable researchers to study
multiple compounds of interest without the burden of
numerous liver animal studies. An example of this is the
series of experiments comparing the metabolism of
diphacinone and chlorophacinone in Wistar rats, brown
rats, and bobwhite quail. It is evident that more
diphacinone than chlorophacinone was metabolized
under the same conditions in all of the species studies.
Although there are wide variations in the published
toxicity data, these results are congruent, with the Wistar
rat LD50 for diphacinone (7.0 mg/kg) being higher than
that for chlorophacinone (3.15 mg/kg) (Fishel 2005,
reviewed in Eisemann and Swift 2006).
These
differences in toxicity are what would be predicted using
only the liver microsome data. Since more of the
diphacinone than chlorophacinone is metabolized, it
follows that diphacinone would be less toxic.
In addition to mirroring the differences between invivo toxicity of diphacinone and chlorophacinone, liver
microsome data also demonstrate differences in species
toxicity. In the liver microsome experiments, bobwhite
quail metabolized 15% more diphacinone and 18% more
chlorophacinone that Wistar rats, with brown rat
microsome metabolism at an intermediate level between
the two. These in-vitro data indicate that both diphacinone and chlorophacinone should be less toxic to
bobwhite quail than rats; this is the trend that is found in
whole animal toxicity tests that report an LD50 for
bobwhite quail between 400 and 2,000 mg/kg, with rat
LD50 being 10 to 100 times higher (US EPA 1998,
reviewed in Eisemann and Swift 2006). The ability to
compare relative toxicities between species is important
during toxicant development, as this information can be
used to direct future whole animal toxicity tests to include
the more sensitive species.
One of the variables that must be considered when
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conducting microsome incubations is the amount of time
the microsomes are incubated with the compound of
interest. If the incubation time it too short, possible
differences in metabolic activity may not be evident
(Figure 3). To determine the differences in metabolism
between Wistar rats and bobwhite quail, it is important to
allow the microsomes to metabolize the diphacinone for
more than 60 minutes to detect differences. If the microsome experiments were terminated after 30 minutes,
information about the distinct metabolic profiles would be
lost.
Advances are being made to use data from liver
microsome experiments to estimate metabolism and
therefore in-vivo doses. Most of the work to date has
been aimed at predicting drug clearance in humans,
although many of these studies use preclinical animal
data (Riley et al. 2005, Boxenbaum 1982). Many papers
have been published concerning the allometric scaling of
data from microsome studies to in-vivo dosing and
clearance (Obach 1999). Although little work has been
done to scale microsome data to whole animal drug
clearance and toxicity in wildlife, this area of research
shows promise in helping scientists choose compounds
for further development. The ability to estimate starting
doses for in-vivo toxicity tests will not only save time and
money for investigators, but it also could decrease the
number of experimental animals used to determine
toxicity levels.

OBACH, R. S. 1999. Prediction of human clearance of twentynine drugs from hepatic microsomal intrinsic clearance
data: An examination of in vitro half-life approach and
nonspecific binding to microsomes. Drug Metab. Disposit.
27:1350-1359.
PELKONEN, O., E. H. KALTIALA, T. K. I. LARMI, and N. T.
KÄRKI. 1974. Cytochrome P-450-linked monooxygenase
system and drug-induced spectral interactions in human
liver microsomes. Chem.-Biol. Interact. 9:205-216.
PELKONEN, O., J. MÄENPÄÄ, P. TAAVITSAINEN, A. RAUTIO, and
H. RAUNIO. 1998. Inhibition and induction of human
cytochrome P450 (CYP) enzymes. Xenobiotica 28:12031253.
RILEY, R., D. F. MCGINNITY, and R. P. AUSTIN. 2005. A
unified model for predicting human hepatic, metabolic
clearance from in-vitro intrinsic data in hepatocytes and
microsomes. Drug Metab. Disposit. 33:1304-1311.
US EPA. 1998. Reregistration eligibility decision (RED):
Rodenticide cluster.
EPA 738-R-98-007, U.S.
Environmental Protection Agency, Washington, DC.
http://www.epa.gov/oppsrrd1/REDs/2100red.pdf.
WRIGHTON, S. A., M. VANDENBRANDEN, J. C. STEVENS, L. A.
SHIPLEY, F. J. RING, A. E. RETTIE, and J. R. CASHMAN.
1993. In vitro methods for assessing human hepatic drug
metabolism: Their use in drug development. Drug Metab.
Rev. 25:453-484.

ACKNOWLEDGEMENTS
The authors would like to acknowledge Gary Witmer for providing
liver tissue for many of these experiments. The authors also thank
Bruce Kimball for helpful revisions of this manuscript. All animal
procedures were approved by the Institutional Animal Care and Use
Committees of the USDA National Wildlife Research Center.

LITERATURE CITED

BOXENBAUM, H. 1982. Interspecies scaling, allometry,
physiological time and the ground plan of pharmacokinetics. J. Phramacokinet. Biopharm. 10:201-227.
EISEMANN, J. D., and C. E. SWIFT. 2006. Ecological and
human health hazards from broadcast application of 0.005%
diphacinone rodenticide baits in native Hawaiian
ecosystems. Proc. Vertebr. Pest Conf. 22:413-433.
FINK-GREMMELS, J. 2008. Implications of hepatic cytochrome
P450-related biotransformation processes in veterinary
sciences. Eur. J. Pharmacol. 585:502-509.
FISHEL, F. M. 2005. Pesticide toxicity profile: Coumarin and
indandione rodenticides. Extension Publication PI-76,
Institute of Food and Agricultural Sciences, Univ. of
Florida. 4 pp.
KLASSEN, C. D. (EDITOR). 2001. Casarett and Doull’s
Toxicology – The Basic Science of Poisons, 6th Ed.
McGraw-Hill, New York, NY. 1,236 pp.
LEWIS, D. F. V., C. LOANNIDES, and D. V. PARKE. 1998.
Cytochrome P450 and species differences in xenobiotic
metabolism and activation of carcinogen. Environ. Health
Perspect. 106:633-640.

198

